Med. Pro Praxi 2009; 6(3): 165-166

Diabetes mellitus and ischaemic stroke

MUDr. Jiří Neumann
Neurologické oddělení s JIP, Nemocnice Chomutov

There are more than 700,000 patients with diabetes mellitus (DM) in the Czech Republic, out of whom over 90 % are classified as type

2 diabetics. Vascular complications of type 2 DM are currently a common cause of morbidity and mortality in diabetic patients. DM is

one of the diseases closely related to ischaemic stroke. In persons with DM, the prevalence of ischaemic stroke is threefold higher compared

to that in the nondiabetic population, and the mortality of diabetics with stroke is also threefold higher. Insufficient compensation

of DM positively correlates with the risk of developing ischaemic stroke. In addition, DM adversely affects the course of ischaemic stroke

and increases the likelihood of more prominent and severe stroke sequelae.

Keywords: diabetes mellitus, ischaemic stroke, risk factors, treatment.

Published: June 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Neumann J. Diabetes mellitus and ischaemic stroke. Med. praxi. 2009;6(3):165-166.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. AHA Scientific Statement. Diabetes mellitus and cardiovascular disease. Circulation 1999; 100: 1134-1146. Go to original source...
    2. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke and death. Arch Internn. Med. 2004; 13: 1422-1426. Go to original source... Go to PubMed...
    3. Anděl M, Kraml P, Dlouhý P, Málková J, Hajer J. Patogenese aterosklerózy: od metabolických změn k chronickému zánětu s aspekty střádavého onemocnění. Prakt. Lék. 1997; 6: 266-275.
    4. Beckman JA, Greager MA, Libby P. Diabetes and atherosclerosis. Epidemiology, pathophysiology, and management. JAMA 2002; 287: 2570-2581. Go to original source... Go to PubMed...
    5. Colwell JA, Nesto RW. The platelet in diabetes. Focus on prevention of ischemic events. Diabetes Care 2003; 26: 2181-2188. Go to original source... Go to PubMed...
    6. Furie K, Inzucchi I. Diabetes mellitus, insulin resistance, hyperglycemia, and stroke. Curr Neurol Neurosci Rep. 2008; 8(1): 12-19. Go to original source... Go to PubMed...
    7. Gorelick PB. Stroke Prevention. Arch Neurol. 1995; 52(347): 355. Go to original source... Go to PubMed...
    8. Heart Protection Study Group. Lancet 2002; 360: 7-22.
    9. Hacke W, Stingele R, Steiner T, Schuchardt V, Schwab S. Critical care of acute ischemic stroke. Intensive Care Med 1995; 21: 856-862. Go to original source... Go to PubMed...
    10. Kalita Z, Souček M, Sachová M. Výskyt rizikových faktorů cévní mozkové příhody v populaci České republiky. Prakt. Lék. 2003; 83: 643-646.
    11. Kalita Z, a kol. Akutní cévní mozkové příhody. Praha: Maxdorf, 2006: 623 s.
    12. Kalita Z, Keller O, Bar M, Mikulík R, Škoda O, Neumann J. Sekundární prevence recidivy po akutní cévní mozkové příhodě [(iCMP) - mozkovém infarktu/tranzitorní ischemické atace (TIA) a hemoragické CMP]. Standardy léčebných postupů a kvalita ve zdravotní péči. Verlag Dashöfer, 2008. NEURO/2: 1-18 s.
    13. Kannel WB, McGee DL. Diabetes and stroke. The Framingham Study. JAMA 1979; 241(19): 2035-2038. Go to original source...
    14. Kernan WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM, Horwitz RI. Insulin resistence and risk for stroke. Neurology 2002; 59: 809-815. Go to original source... Go to PubMed...
    15. Kernan WN, Inzuchi SE. Type 2 diabetes mellitus and insulin resistance: stroke prevention and management. Curr Treat Options Neurol. 2004; 6: 443-450. Go to original source... Go to PubMed...
    16. Kvapil M. Diabetes mellitus a cévní mozkové příhody. Lék Listy 2006; 7: 19-21.
    17. Mikulík R, Neumann J, Školoudík D, Václavík D. Standard pro diagnostiku a léčbu pacientů s mozkovým infarktem. Cesk Slov Neurol. 2006; 4: 320-325.
    18. Neumann J, Mikulík R Václavík D, Školoudík D. Standard pro diagnostiku a léčbu pacientů po tranzitorní ischemické atace. Cesk Slov Neurol. 2006; 4: 326-330.
    19. Sacco RT, et al. Guidelines for Prevention of Stroke in Patients with Ischemic Stroke or Transient Ischemic Attack. Stroke, 2006; 2: 577-617. Go to original source... Go to PubMed...
    20. Standardy péče o diabetes mellitus 2. typu - aktualizace 2007. Česká diabetologická společnost.
    21. Wolf PA, Belangner AJ, D´Agostino RB. Management of risk factors. Neurol Clin. 1992; 10: 177-191. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.